Overview

Use of Tranexamic Acid in Blepharoplasties

Status:
Recruiting
Trial end date:
2023-02-20
Target enrollment:
0
Participant gender:
All
Summary
The goal of this investigation is to assess whether or not there is a significant difference in the presence and/or degree of post-operative ecchymosis, pain, and edema between groups of patients undergoing upper lid blepharoplasty with traditional local anesthetic (LA) and those who receive tranexamic acid (TXA) in addition to traditional LA.
Phase:
Phase 3
Accepts Healthy Volunteers?
Accepts Healthy Volunteers
Details
Lead Sponsor:
Northwestern University
Treatments:
Tranexamic Acid
Criteria
Inclusion Criteria:

- any adult patient who is undergoing upper lid blepharoplasty with author Douglas
Sidle, MD and who is older than 18 years of age, fluent in English, not on any
anticoagulant or antiplatelet medication (e.g. aspirin, clopidogrel, etc.), not
diagnosed with a coagulation disorder, not pregnant, not undergoing a simultaneous
procedure, and not a Feinberg School of Medicine (FSM) student or Northwestern
Memorial (NM) employee.

Exclusion Criteria:

- less than 18 years of age, not fluent in English, taking anticoagulant or
antiplatelet, has coagulation disorder, pregnant, simultaneous procedure, FSM or NM
student/employee